Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients
Clinical trial NCT04835883 · UNKNOWN
Trial details
- NCT number
- NCT04835883
- Sponsor
- Hanyang University Seoul Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2021-11-05
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.